These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 25436720)

  • 1. Menopausal status, adipose tissue, and breast cancer risk: impact of estrogen replacement therapy.
    Eden JA
    Horm Mol Biol Clin Investig; 2013 Aug; 14(2):57-63. PubMed ID: 25436720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer, stem cells and sex hormones. Part 3: the impact of the menopause and hormone replacement.
    Eden JA
    Maturitas; 2011 Feb; 68(2):129-36. PubMed ID: 21145188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of obesity on breast cancer receptor status and prognosis.
    Rose DP; Vona-Davis L
    Expert Rev Anticancer Ther; 2009 Aug; 9(8):1091-101. PubMed ID: 19671029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR; Gadducci A; Gambacciani M
    Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between menopausal status and obesity in affecting breast cancer risk.
    Rose DP; Vona-Davis L
    Maturitas; 2010 May; 66(1):33-8. PubMed ID: 20181446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk.
    Furberg AS; Veierød MB; Wilsgaard T; Bernstein L; Thune I
    J Natl Cancer Inst; 2004 Aug; 96(15):1152-60. PubMed ID: 15292387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Why does oestrogen-only hormone therapy have such a small impact on breast cancer risk? A hypothesis.
    Eden JA
    Gynecol Endocrinol; 2011 Mar; 27(3):170-5. PubMed ID: 20500114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of body weight to menarcheal and menopausal age: implications for breast cancer risk.
    Sherman B; Wallace R; Bean J; Schlabaugh L
    J Clin Endocrinol Metab; 1981 Mar; 52(3):488-93. PubMed ID: 7462400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Menopausal estrogen replacement therapy and breast cancer.
    Dupont WD; Page DL
    Arch Intern Med; 1991 Jan; 151(1):67-72. PubMed ID: 1824675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Female sex hormones increase the risk of breast cancer].
    Vatten L
    Tidsskr Nor Laegeforen; 1998 Aug; 118(19):2969-74. PubMed ID: 9748837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Breast cancer and the use of the hormones around the menopause].
    Vandenbroucke JP; van Leeuwen FE; Helmerhorst FM
    Ned Tijdschr Geneeskd; 2003 Sep; 147(38):1829-34. PubMed ID: 14533492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Menopause and hormone replacement therapy].
    Tóth KS
    Orv Hetil; 2000 Mar; 141(11):547-56. PubMed ID: 10741167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous and exogenous endocrine factors.
    Henderson BE
    Hematol Oncol Clin North Am; 1989 Dec; 3(4):577-98. PubMed ID: 2691490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer epidemiology.
    Kelsey JL; Berkowitz GS
    Cancer Res; 1988 Oct; 48(20):5615-23. PubMed ID: 3048646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lifetime weight history and endometrial cancer risk by type of menopausal hormone use in the NIH-AARP diet and health study.
    Chang SC; Lacey JV; Brinton LA; Hartge P; Adams K; Mouw T; Carroll L; Hollenbeck A; Schatzkin A; Leitzmann MF
    Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):723-30. PubMed ID: 17416763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer.
    van Leeuwen FE
    Acta Endocrinol (Copenh); 1991; 125 Suppl 1():13-26. PubMed ID: 1801500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer risk in the WHI study: the problem of obesity.
    Kuhl H
    Maturitas; 2005 May; 51(1):83-97. PubMed ID: 15883113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of endogenous and exogenous hormones on breast cancer: epidemiology.
    Vessey MP
    Verh Dtsch Ges Pathol; 1997; 81():493-501. PubMed ID: 9474890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevention of breast cancer through reduced ovarian steroid exposure.
    Spicer DV; Pike MC
    Acta Oncol; 1992; 31(2):167-74. PubMed ID: 1622631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.